Stop Wasting Millions on Biomarkers That Will Fail

Our AI tells you the truth about clinical potential before you invest in expensive validation studies

The Biomarker Reality Crisis

90%
Biomarker failure rate
$2.6B
Wasted annually
99%
Suspicious accuracy claims
O_O
Your face reading this
researcher@biotech:~$ clarified analyze overly_optimistic_study.csv
Analyzing biomarker validation study...
Processing 847 samples, 23 features, 1 very suspicious claim...
⚠️ WARNING: 99.8% accuracy suggests overfitting
⚠️ Sample size insufficient for generalization
⚠️ Study design lacks proper validation controls
Realistic accuracy estimate: 67-73%
Recommendation: Redesign study before Phase II investment
researcher@biotech:~$ echo "O_O that could have saved us $2M"
O_O that could have saved us $2M

Our Solutions

Preventing biomarker failures before they happen

Study Design Validator

Upload your research proposal and get a realistic feasibility assessment. We identify potential failure points and suggest design improvements before you spend money.

AI Interpretation Audit

Already have AI results that seem too good to be true? Our constraint-aware analysis provides realistic assessments and identifies interpretation issues.

Biomarker Evaluation

Complete clinical translation pathway analysis. Get clear go/no-go decisions with ROI projections for further biomarker development investment.